NOBBIO, LUCILLA
 Distribuzione geografica
Continente #
EU - Europa 7.921
AS - Asia 881
NA - Nord America 363
SA - Sud America 59
AF - Africa 12
OC - Oceania 1
Totale 9.237
Nazione #
IT - Italia 7.795
SG - Singapore 378
US - Stati Uniti d'America 332
CN - Cina 221
VN - Vietnam 168
FR - Francia 60
HK - Hong Kong 37
BR - Brasile 34
MX - Messico 15
JP - Giappone 14
AR - Argentina 13
BD - Bangladesh 12
CA - Canada 12
FI - Finlandia 10
DE - Germania 9
ID - Indonesia 9
IN - India 9
CH - Svizzera 7
IQ - Iraq 7
NL - Olanda 7
GB - Regno Unito 6
ES - Italia 4
ZA - Sudafrica 4
AT - Austria 3
BE - Belgio 3
EC - Ecuador 3
IL - Israele 3
LV - Lettonia 3
MY - Malesia 3
PL - Polonia 3
SA - Arabia Saudita 3
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
GR - Grecia 2
IE - Irlanda 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
PK - Pakistan 2
VE - Venezuela 2
AU - Australia 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MZ - Mozambico 1
PS - Palestinian Territory 1
PY - Paraguay 1
RU - Federazione Russa 1
SE - Svezia 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 9.237
Città #
Genova 4.255
Genoa 2.156
Rapallo 762
Vado Ligure 553
Singapore 189
San Jose 125
Lauterbourg 54
Hanoi 49
Ho Chi Minh City 46
Ashburn 37
Hong Kong 35
Beijing 26
New York 24
Bordighera 17
Rome 16
Council Bluffs 15
Tokyo 13
Milan 12
Helsinki 10
Biên Hòa 9
Mexico City 8
Santa Clara 8
Los Angeles 7
Zurich 7
Baghdad 6
Da Nang 6
Frankfurt am Main 6
Haiphong 6
Montreal 6
Amsterdam 5
Buffalo 5
Orem 5
Guangzhou 4
São Paulo 4
Turin 4
Bắc Ninh 3
Can Tho 3
Changsha 3
Dhaka 3
Johannesburg 3
Riga 3
Shanghai 3
Shenzhen 3
Vĩnh Tường 3
Warsaw 3
Anderlecht 2
Athens 2
Atlanta 2
Bologna 2
Brooklyn 2
Chennai 2
Chicago 2
City of London 2
Dammam 2
Dublin 2
Fortaleza 2
Houston 2
Jaipur 2
Jakarta 2
Kathmandu 2
Lahore 2
León 2
Marseille 2
Nantong 2
Piscataway 2
Salt Lake City 2
São José dos Campos 2
Toronto 2
Valencia 2
Valenza 2
Ấp Tháp Mười 2
Acalanes Ridge 1
Agadir 1
Agawam 1
Alliston 1
Americana 1
Amman 1
Ananindeua 1
Arapiraca 1
Araxá 1
Arroio Grande 1
Asunción 1
Augusta 1
Bangkok 1
Barranquilla 1
Belém 1
Bengkulu 1
Bergamo 1
Berlin 1
Bogotá 1
Bojonegoro 1
Bonito 1
Boston 1
Brazzaville 1
Brussels 1
Buenos Aires 1
Bălţi 1
Bến Tre 1
Calgary 1
Capão do Leão 1
Totale 8.601
Nome #
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 217
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies 205
Does parkin play a role in the peripheral nervous system? A family report 204
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 199
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A 195
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 184
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 183
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. 182
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 180
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 180
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. 180
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 174
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy 172
Mitichondrial dysfunction in experimental Charcot-marie-Tooth type 1° (CMTIA) neuropathy: a possible key factor for the axonal degeneration 171
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 168
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 167
Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease 162
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 161
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 158
Correlation among demyelination and axonal degeneration: a new trophic role for myelin sheath 156
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 155
Mifepristone (RU 38486) influences expression of glycoprotein Po and morphological parameters at the level of rat sciatic nerve: In vivo observations . 151
Inherited Peripheral Neuropathies 148
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 147
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 144
Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7. 143
Oxydative phosphorilation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 142
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 142
P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy 140
Ebf Genes In Peripheral Nerve Myelination 138
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 138
Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 138
Synaptopodin and 4 novel genes identified in primary sensory neurons. 138
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 134
P2X7 antagonism in experimental CMT1A: a potential therapeutic strategy 134
PMP22 messenger RNA levels in skin biopsies: Testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker 133
Ebf genes' silencing impairs myelin formation 127
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 125
The transcription factors EBF1 and EBF2 are positive regulators of myelination in Schwann cells 125
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism 125
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 124
The diadenosine homodinucleotide P18 improvesin vitromyelination in experimental Charcot-Marie-Tooth type 1A 123
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 123
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial. 121
Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy. 121
Energetic disfunction in CMT1A: role of myelin and neuron mitochondria 120
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 120
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 120
P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 119
P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 118
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neuropathy. 116
Energy supply and demyelinising diseases: a new trophic role of myelin sheath. 114
Energetic metabolism of myelinated axons: a new correlation among axonal degeneration, demyelination and energy supply. 112
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neurophaty. 111
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 110
Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerations 109
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 (PMP22) 108
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 105
Functional Characterization of Hyccin, a Novel Membrane Protein Involved in Central and Peripheral Myelination 103
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 97
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 95
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 92
Neuropatie di Charcot-Marie-Tooth: dalla patologia alla patogenesi 75
Inherited neuropathies. 72
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 65
Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders? 63
Increased [18F]DPA-714 Uptake in the Skeletal Muscle of SOD1G93A Mice: A New Potential of Translocator Protein 18 kDa Imaging in Amyotrophic Lateral Sclerosis 59
null 48
Basic Pathological Mechanisms in Peripheral Nerve Diseases 39
Techniques for the standard histological and ultrastructural assessment of nerve biopsies 34
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients 22
Totale 9.323
Categoria #
all - tutte 28.942
article - articoli 22.297
book - libri 0
conference - conferenze 6.221
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 424
Totale 57.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 0 29 30
2021/2022756 16 69 51 86 20 48 44 186 32 63 31 110
2022/2023885 74 82 7 83 173 132 2 81 139 6 94 12
2023/2024494 31 51 15 63 36 85 58 39 22 10 23 61
2024/20251.426 96 83 52 104 167 126 111 272 53 48 154 160
2025/20262.192 372 71 133 160 422 176 359 110 150 239 0 0
Totale 9.323